iShares Nasdaq Biotechnology ETF (IBB) Position Increased by TRUE Private Wealth Advisors

TRUE Private Wealth Advisors increased its holdings in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 15.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,640 shares of the financial services provider’s stock after acquiring an additional 483 shares during the quarter. TRUE Private Wealth Advisors’ holdings in iShares Nasdaq Biotechnology ETF were worth $444,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of IBB. Schroder Investment Management Group bought a new stake in shares of iShares Nasdaq Biotechnology ETF in the second quarter valued at $105,000. Bay Colony Advisory Group Inc d b a Bay Colony Advisors bought a new stake in shares of iShares Nasdaq Biotechnology ETF in the second quarter valued at $134,000. KHP Capital LLC raised its stake in shares of iShares Nasdaq Biotechnology ETF by 61.1% in the second quarter. KHP Capital LLC now owns 1,450 shares of the financial services provider’s stock valued at $159,000 after buying an additional 550 shares during the period. Private Wealth Advisors Inc. bought a new stake in shares of iShares Nasdaq Biotechnology ETF in the second quarter valued at $201,000. Finally, Valmark Advisers Inc. bought a new stake in shares of iShares Nasdaq Biotechnology ETF in the second quarter valued at $202,000. Hedge funds and other institutional investors own 64.65% of the company’s stock.

Shares of IBB opened at $112.99 on Friday. iShares Nasdaq Biotechnology ETF has a 1 year low of $100.22 and a 1 year high of $122.97.

The company also recently announced a quarterly dividend, which was paid on Tuesday, October 2nd. Shareholders of record on Thursday, September 27th were paid a $0.0324 dividend. The ex-dividend date of this dividend was Wednesday, September 26th. This represents a $0.13 annualized dividend and a dividend yield of 0.11%.

About iShares Nasdaq Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Further Reading: Hedge Funds – Risk or Reward?

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply